Bleeding in Patients with Renal Impairment: A Current Perspective.

Area of Science:

• Nephrology
• Hematology
• Internal Medicine

Background:

• Bleeding complications are common and significant in chronic kidney disease (CKD), worsening with declining kidney function and dialysis.
• The tendency for bleeding in CKD is multifactorial, involving platelet dysfunction, uremic/inflammatory states, renal anemia, and anticoagulant use.

Purpose of the Study:

• To review the mechanisms of bleeding in CKD.
• To highlight the limitations of current bleeding risk assessment tools in CKD patients.
• To explore the potential of albuminuria as a marker for improved bleeding risk stratification.

Main Methods:

• Literature review summarizing pathophysiological mechanisms of bleeding in CKD.
• Analysis of the impact of dialysis and declining renal function on hemostasis.
• Evaluation of emerging evidence on albuminuria as a bleeding risk marker.

Main Results:

• Bleeding in CKD results from impaired hemostasis due to platelet dysfunction, uremia, anemia, and anticoagulation.
• Existing bleeding risk tools are inadequate for the CKD population.
• Albuminuria shows promise as an independent marker for renal dysfunction and hemorrhage risk.

Conclusions:

• There is a significant unmet need for CKD-specific bleeding risk assessment tools.
• Albuminuria may improve the stratification of bleeding risk in patients with chronic kidney disease.
• Understanding multifactorial bleeding mechanisms is crucial for clinical management.